Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1124011473
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3737 Market St, 8th Floor
Philadelphia, PA, 19104
Phone (215) 662-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
621 services
Medicare patients, 2024
206
Average age 72
Drug cost, 2024
$22.9M
3,041 prescriptions
Company payments, 2025
$34K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sami L Khella was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 157 times for 123 patients. In total Sami L Khella billed 621 services in 23 codes, and Medicare paid $37K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 157 | 123 | $13.16 | $2,066 |
| 99214 Office E&M - Established | Facility | 104 | 80 | $70.36 | $7,317 |
| 99215 Office E&M - Established | Facility | 98 | 70 | $102.50 | $10K |
| 95886 Electrical Nerve Conductivity | Office | 49 | 36 | $35.17 | $1,723 |
| 99205 Office E&M - New | Facility | 29 | 29 | $143.17 | $4,152 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 26 | $11.85 | $320 |
| 95910 Electrical Nerve Conductivity | Office | 20 | 20 | $83.71 | $1,674 |
| 95885 Electrical Nerve Conductivity | Office | 17 | 14 | $14.61 | $248 |
| 99202 Office E&M - New | Office | 12 | 12 | $50.44 | $605 |
| 95912 Electrical Nerve Conductivity | Office | 11 | 11 | $124.53 | $1,370 |
By year: 2022 $46K for 537 services; 2023 $43K for 547 services; 2024 $37K for 621 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sami L Khella prescribed most often to Medicare patients was Prednisone, with 547 prescriptions and refills. In total Sami L Khella wrote 3,041 Medicare prescriptions that cost $22.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 547 | 766 | 66 | $3,193 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 407 | 407 | 26 | $4.4M |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 278 | 284 | 14 | $2.8M |
| Sodium Chloride 0.9 % Sodium Chloride | 178 | 202 | 56 | $693 |
| Gabapentin Generic | 163 | 263 | 43 | $4,907 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 120 | 129 | Under 11 | $1.7M |
| Ultomiris Ravulizumab-Cwvz | 116 | 157 | Under 11 | $4.7M |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 96 | 96 | Under 11 | $775K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 92 | 92 | Under 11 | $700K |
| Mycophenolate Mofetil Generic | 89 | 174 | 19 | $10K |
| Pyridostigmine Bromide Generic | 87 | 169 | 32 | $9,182 |
| Diphenhydramine Hcl Generic | 72 | 129 | 57 | $211 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 66 | 66 | Under 11 | $989K |
| Sodium Chloride Sodium Chloride 0.45 % | 46 | 46 | Under 11 | $331 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 45 | 45 | Under 11 | $441K |
Brand drugs: 1,622 claims; generic drugs: 1,419 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sami L Khella $34K ($34K in general payments such as food, travel and fees) from 13 companies. The largest payer was Argenx US, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 26 | $23K |
| Pfizer Inc. PFE | 4 | $8,540 |
| AstraZeneca UK Limited AZN | 1 | $650 |
| Amgen Inc. AMGN | 1 | $613 |
| CSL Behring CSL.AX | 2 | $365 |
| UCB, Inc. UCB.BR | 2 | $242 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $235 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $158 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $34.18 |
| Abbvie Inc. ABBV | 1 | $33.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.